Paulke A - Search Results

1

Excretion of 4-fluoroamphetamine and three metabolites in urine after controlled oral ingestion.

Toennes SW, Schneider D, Pogoda W, Paulke A, Wunder C, Theunissen EL, de Sousa Fernandes Perna EB, Ramaekers JG. Toennes SW, et al. Among authors: paulke a. J Pharm Biomed Anal. 2020 Feb 5;179:113008. doi: 10.1016/j.jpba.2019.113008. Epub 2019 Nov 23. J Pharm Biomed Anal. 2020. PMID: 31785931

2

Investigation of a recently detected 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol isomer: Studies on the degradation of 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol glucuronide.

Hanisch S, Paulke A, Toennes SW. Hanisch S, et al. Among authors: paulke a. J Pharm Biomed Anal. 2016 Sep 10;129:294-298. doi: 10.1016/j.jpba.2016.07.019. Epub 2016 Jul 14. J Pharm Biomed Anal. 2016. PMID: 27448313

3

Pharmacokinetic properties of the synthetic cannabinoid JWH-018 and of its metabolites in serum after inhalation.

Toennes SW, Geraths A, Pogoda W, Paulke A, Wunder C, Theunissen EL, Ramaekers JG. Toennes SW, et al. Among authors: paulke a. J Pharm Biomed Anal. 2017 Jun 5;140:215-222. doi: 10.1016/j.jpba.2017.03.043. Epub 2017 Mar 24. J Pharm Biomed Anal. 2017. PMID: 28365515

4

11-nor-9-carboxy-Δ⁹-tetrahydrocannabinol glucuronide exhibits acyl-migration isomers.

Hanisch S, Paulke A, Toennes SW. Hanisch S, et al. Among authors: paulke a. J Pharm Biomed Anal. 2017 Nov 30;146:261-265. doi: 10.1016/j.jpba.2017.08.044. Epub 2017 Aug 31. J Pharm Biomed Anal. 2017. PMID: 28892757

5

Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.

Toennes SW, Geraths A, Pogoda W, Paulke A, Wunder C, Theunissen EL, Ramaekers JG. Toennes SW, et al. Among authors: paulke a. Drug Test Anal. 2018 Apr;10(4):644-650. doi: 10.1002/dta.2310. Epub 2017 Nov 23. Drug Test Anal. 2018. PMID: 28967189

6

Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation.

Toennes SW, Geraths A, Pogoda W, Paulke A, Wunder C, Theunissen EL, Ramaekers JG. Toennes SW, et al. Among authors: paulke a. J Pharm Biomed Anal. 2018 Feb 20;150:162-168. doi: 10.1016/j.jpba.2017.12.016. Epub 2017 Dec 9. J Pharm Biomed Anal. 2018. PMID: 29245085 Clinical Trial.

7

Pharmacokinetic properties of 4-fluoroamphetamine in serum and oral fluid after oral ingestion.

Toennes SW, Schneider D, Pogoda W, Paulke A, Wunder C, Theunissen EL, Kuypers KPC, de Sousa Fernandes Perna E, Ramaekers JG. Toennes SW, et al. Among authors: paulke a. Drug Test Anal. 2019 Jul;11(7):1028-1034. doi: 10.1002/dta.2595. Epub 2019 May 2. Drug Test Anal. 2019. PMID: 30912312 Clinical Trial.

8

Identification of legal highs--ergot alkaloid patterns in two Argyreia nervosa products.

Paulke A, Kremer C, Wunder C, Wurglics M, Schubert-Zsilavecz M, Toennes SW. Paulke A, et al. Forensic Sci Int. 2014 Sep;242:62-71. doi: 10.1016/j.forsciint.2014.06.025. Epub 2014 Jun 30. Forensic Sci Int. 2014. PMID: 25036782

9

Retrospective analysis of synthetic cannabinoids in serum samples--epidemiology and consumption patterns.

Jaenicke NJ, Pogoda W, Paulke A, Wunder C, Toennes SW. Jaenicke NJ, et al. Among authors: paulke a. Forensic Sci Int. 2014 Sep;242:81-87. doi: 10.1016/j.forsciint.2014.06.010. Epub 2014 Jun 23. Forensic Sci Int. 2014. PMID: 25050839

10

Pitfall in cannabinoid analysis--detection of a previously unrecognized interfering compound in human serum.

Toennes SW, Hanisch S, Pogoda W, Wunder C, Paulke A. Toennes SW, et al. Among authors: paulke a. Anal Bioanal Chem. 2015 Jan;407(2):463-70. doi: 10.1007/s00216-014-8301-y. Epub 2014 Nov 13. Anal Bioanal Chem. 2015. PMID: 25391576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters